Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models
Mark Yeomans, Ernst & Young LLP
Advertisement
Articles by Mark Yeomans, Ernst & Young LLP
Advertisement
Latest Updated Articles
- Supply chains for a patient-centric world
May 30th 2012
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
When Drug Pricing Collides With Politics
2
The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation
3
Idle US Capacity Could Anchor Generic Drug Reshoring, APIIC Says
4
How CMS’ Final Negotiation Rule Treats New Drug Formulations
5